2nd Annoucnement:
International Symposium on the 5th anniversary of the Basel Institute for Clinical Epidemiology
Revisiting endpoints and stopping rules in clinical trials:
Current dilemmas and future directions
Thursday September 28, 2006
University Hospital Basel, Switzerland
The issues of appropriate endpoint selection and stopping rules when terminating trials early for benefit from interventions are of crucial importance both for researchers involved in the planning and analysis of clinical trials and for clinicians whose daily work encompasses the integration of trial evidence with care of the the individual patient.
Speakers: Jacobus Lubsen Erasmus University, Gordon Guyatt McMaster University, Heiner C. Bucher University of Basel, André Knottnerus University of Maastricht, Doug Altman Oxford University
We would like to welcome you to our symposium and are looking forward to a challenging discussion.
Heiner C. Bucher Regina Kunz
Prof. Dr. Heiner C. Bucher MPH
Institut für klinische Epidemiologie
Universitätsspital Basel
CH-4031 Basel
Switzerland
Phone 0041-61-265 3101
Fax 0041-61-265 3109
Email [log in to unmask]
Prof. Dr. Heiner C. Bucher MPH
Institut für klinische Epidemiologie
Universitätsspital Basel
CH-4031 Basel
Switzerland
Phone 0041-61-265 3101
Fax 0041-61-265 3109
Email [log in to unmask]
|